Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00425230 · ClinicalTrials.gov registry record · NA
Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain
A NA study, sponsored by Baylor College of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00425230: Clinical Trial NA study, sponsored by Baylor College of Medicine.
NCT00425230 is a NA study that was terminated before completion, run by Baylor College of Medicine. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00425230, a NA study, was terminated before completion, sponsored by Baylor College of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a study to assess the possible benefit of duloxetine in the treatment of chronic phantom limb pain.
Interventions
- DRUG Duloxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2007-01 |
| Est. Completion | 2007-06 |
| Phase | NA |
Why NCT00425230 stopped before completion
NCT00425230 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Duloxetine is the first listed.
NCT00425230 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00425230 about?
NCT00425230 is a clinical study titled "Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain". This is a study to assess the possible benefit of duloxetine in the treatment of chronic phantom limb pain.
What is the current status of trial NCT00425230?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2007-01. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00425230?
The interventions under investigation include: Duloxetine (DRUG).
Who is sponsoring clinical trial NCT00425230?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00425230's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia